Jessica Robin is the Director of Clinical Research at Winterlight Labs.
How Speech-Based Digital Biomarkers are Redefining the Measurement of Disease Progression in Neurodegenerative Dementia Trials
Future shows great potential for neurological language assessments in clinical trials.